Microbiota and Hepatobiliary Diseases: New Features in the Treatment of Infants

O.H. Shadrin, N.F. Cherneha

Abstract


In infants with hepatitis, clinically significant dysbiotic disorders of the intestine are observed. The state of intestinal flora is characterized by a deficiency of resident microflora, increased number and changes in species ratio of oppor­tunistic bacteria. Application of Enterol® (Saccharomyces boulardii) in children with intestinal dysbiosis and liver disease has a positive impact on the course of the disease, would reduce diarrheal disorders and restore intestinal microflora.


Keywords


hepatitis; intestinal microflora; Saccharomyces boulardii; infants

References


Чихачева Е., Селиверстов П., Тетерина Л., Добрица В. Микробиоценоз кишечника при хронических заболеваниях печени: диагностика и лечение // Лечащий врач. — 2011. — № 7. — С. 18-21.

Закиров И.Г. Дисбактериоз кишечника при хронических вирусных гепатитах. — Казань, 2003. — 86 с.

Levi A.C., Borghi F., Petrino R., Bargoni A., Fronticelli C.M., Gentilli S. Modifications of the trophism of intestinal mucosa after intestinal and bilio-pancreatic diversion in the rat // Ital. J. Gastroenterol. — 1991. — 23 (4). — 202-7.

Barbosa T., Rescigno M. Host-bacteria interactions in the intestine: homeostasis to chronic inflammation // Wiley Interdiscip. Rev. Syst. Biol. Med. — 2010. — 2. — 80-97.

Chen C., Li L., Wu Z., Chen H., Fu S. Effects of lactitol on intestinal microflora and plasma endotoxin in patients with chronic viral hepatitis // J. Infect. — 2007. — 54 (1). — 98-102; doi: 10.1016/j.jinf.2005.11.013.

Riordan S.M., Williams R. The intestinal flora and bacterial infection in cirrhosis // J. Hepatol. — 2006. — 45 (5). — 744-57; doi: 10.1016/j.jhep.2006.08.001.

Luyer M.D., Buurman W.A., Hadfoune M., Speelmans G., Knol J., Jacobs J.A. et al. Strain-specific effects of probiotics on gut barrier integrity following hemorrhagic shock // Infect. Immun. — 2005. — 73 (6). — 3686-92; doi: 10.1128/IAI.73.6.3686-3692.2005.

Rachmilewitz D., Katakura K., Karmeli F., Hayashi T., Reinus C., Rudensky B., et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis // Gastroentero­logy. — 2004. — 126 (2). — 520-8

Shaykhiev R., Behr J., Bals R. Microbial patterns signaling via Toll-like receptors 2 and 5 contribute to epithelial repair, growth and survival // PLoS One. — 2008. — 3. — e1393.

Chamberlain N.D., Vila O.M., Volin M.V., Vol­kov S., Pope R.M., Swedler W., Mandelin A.M. 2nd, Shahrara S. TLR5, a novel and unidentified inflammatory mediator in rheumatoid arthritis that correlates with disease activity score and joint TNF-alpha levels // J. Immunol. — 2012. — 189. — 475-483.

Pitt H.A. Hepato-pancreato-biliary fat: the good, the bad, the ugly // Informa Health care. — 2007. — Vol. 9. — P. 92-97.

Kishino S., Takeuchi M., Park S.-B. еt al. Polyunsaturated fatty acid saturation by gut lactic acid bacteria affecting host lipid composition // P. Natl. Acad. Sci USA. — 2013. — 110. — 17808-13.

Schnabl B., Brenner D.A. Interactions between the intestinal microbiome and liver diseases // Gastroentero­logy. — 2014. — 146. — 1513-24.

Joyce S.A., MacSharry J., Casey P.G. et al. Regulation of host weight gain and lipid metabolism by bacterialbile acid modification in the gut // P. Natl. Acad. Sci USA. — 2014. — 111. — 7421-6.

Rahman R., Hammoud G.M., Almashhrawi A.A. et al. Primary hepatocellular carcinoma and metabolic syndrome: an update // World J. Gastrointestinal Onco­logy. — 2013. — Vol. 5. — P. 186-194.

Guarner F., Khan A.G., Garisch J. et al. World Gastroente­rology Organisation Global Guidelines: Pro­biotics and prebiotics, October 2011 // J. Clin. Gastro­enterol. — 2012. — 46 (6). — 468-481.

Hania Szajewska, Alfredo Guarino, Iva Hojsak, Flavia Indrio, Sanja Kolacek, Raanan Shamir, Yvan Vandenplas, and Zvi Weizman, on Behalf of the ESPGHAN Working Group for Probiotics and Prebiotics, Use of Probiotics for Management of Acute Gastro­enteritis: A Position Paper by the ESPGHAN Working Group for Probiotics and Prebiotics // JPGN. — April 2014. — Vol. 58, № 4.

Шабалов Н.П. Неонатология: Учебное пособие: В 2 т. / Шабалов Н.П. — 4-е изд. — Т. 1. — М.: МЕДпресс-информ, 2006. — 608 с.

Куваєва І.Б., Ладодо К.С. Мікроекологічні й імунні порушення в дітей. — М., 1991.

Vleggaar F.P., Monkelbaan J.F., van Erpecum K.J. Pro­biotics in primary sclerosing cholangitis: a randomized placebo-controlled crossover pilot study // Eur. J. Gastroenterol. Hepatol. — 2008. — 20 (7). — 688-92. doi: 10.1097/MEG.0b013e3282f5197e.

Solga S.F. Probiotics can treat hepatic ence­phalopathy // Med. Hypotheses. — 2003. — 61 (2). — 307-13.

Rayes N., Seehofer D., Hansen S., Boucsein K., Muller A.R., Serke S. еt al. Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients // Transplantation. — 2002. — 74 (1). — 123-7.

Волосовец А.П., Бережной В.В., Кривопустов С.П. Клиническое применение saccharomyces boulardii в современной педиатрии: доказательная база // Современная педиатрия. — 2009. — 12. — 11. — http://medexpert.org.ua




DOI: https://doi.org/10.22141/2224-0551.5.65.2015.74877

Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 CHILD`S HEALTH

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2017

 

 Яндекс.МетрикаSeo анализ сайта Рейтинг@Mail.ru